Vanguard Group Inc Royalty Pharma PLC Put Options Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RPRX
# of Institutions
429Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.29 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY23MShares$750 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$553 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$461 Million0.28% of portfolio
-
Viking Global Investors LP12.2MShares$398 Million1.05% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...